Real-time enrollment status for this invasive mould infection clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:27 PM UTC
| NCT Number | NCT07215273 |
| Recruiting Status | Recruiting |
| Condition | Invasive Mould Infection |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Elion Therapeutics, Inc. |
| Last Updated on CT.gov | August 25, 2026 (3 days ago) |
As of August 28, 2026: Clinical trial NCT07215273 is currently recruiting participants. This phase2 study for invasive mould infection is actively seeking new participants at 7 locations across the United States. The study is sponsored by Elion Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07215273 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07215273 was last updated 3 days ago (August 25, 2026). HelloStudys verifies this status automatically.